Clinical Study
Second Surgery in Insular Low-Grade Gliomas
Table 2
Summary of characteristics at tumor recurrence in the subgroup of patients who underwent a second surgery.
| | Parameter | Value |
| | Number of patients | 23 | | Sex | | | Female | 8 (34.78%) | | Male | 15 (65.22%) | | Mean age (yrs) | 42 (range 25–54) | | Tumor side | | | Left | 15 (65.22%) | | Right | 8 (34.78%) | | Median time to tumor recurrence | 81 months (14–124) | | Seizures relapse at second surgery | 11 (47.83%) | | New contrast enhancement before second surgery | 11 (47.83%) | | Intraoperative protocol | | | Awake surgery | 16 (69.57%) | | General anesthesia | 7 (30.43%) | | Immediate postoperative findings | | | No deficits | 15 (65.22%) | | Neurological deficits | 08 (34.78%) | | Motor deficits | 4 (17.39%) | | Speech disorders | 3 (13.04%) | | Visual field disorders | 1 (4.35%) | | Clinical outcome 6 months after surgery | | | No deficits | 22 (95.65%) | | Neurological deficits | 1 (4.35%) | | Histological data | | | LGGs (WHO II) | 6 (26.09%) | | Anaplastic gliomas (WHO III) | 7 (30.43%) | | Glioblastomas (WHO IV) | 10 (43.48%) | | Mib1-Ki-67 expression | 16.5% (range 2–70%) |
|
|
